DexCom, Inc. DXCM
NASDAQ · United States · Health Technology
$87.20+0.90 (+1.05%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | 0.70 | 0.61 | +14.6% | $1.31B | +1.4% | +11.1%$75.14→$83.45 |
| Q1 2026 | 2026-04-30 | 0.56 | 0.47 | +19.1% | — | — | +6.6%$57.56→$61.35 |
| Q4 2025 | 2026-02-12 | 0.68 | 0.65 | +4.6% | — | — | +2.7%$68.15→$70.02 |
| Q3 2025 | 2025-10-30 | 0.61 | 0.57 | +7.0% | — | — | -14.6%$68.18→$58.22 |
| Q2 2025 | 2025-07-30 | 0.48 | 0.44 | +9.1% | — | — | — |
| Q1 2025 | 2025-05-01 | 0.32 | 0.33 | -3.0% | — | — | — |
| Q4 2024 | 2025-02-13 | 0.45 | 0.50 | -10.0% | — | — | — |
| Q3 2024 | 2024-10-24 | 0.45 | 0.43 | +4.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.